Skip to content

A normalization research on extracorporeal life support technology to rescue children with acute respiratory distress syndrome

A normalization research on extracorporeal life support technology to rescue children with acute respiratory distress syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036860
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Interventions

Case series:none

Sponsors

Shanghai Children's Hosptial
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.1 Years to 14 Years

Inclusion criteria

Inclusion criteria: (1) Children are diagnosed as refractory hypoxic respiratory failure /ARDS in PICU. The diagnostic criteria for refractory hypoxic respiratory failure is that the development of respiratory failure could not be prevented by pulmonary protective ventilation strategy, conservative fluid management, prone position, neuromuscular junction blockers, etc. PaO2/FiO2 1hr), (4)Or shock VIS > 100 [vasoactive drug index (VIS)=100 x adrenal (ug/kg.min)+100x norepinephrine (ug/kg.min)+10x milrinone(ug/kg.min)+1x dopamine (ug/kg.min)+1x dobutamine (ug/kg.min)] (VIS reference for measurement [Gaies MG, Gurney JG, Yen AH, Et al. Vasoactive-inotropic Score as a predictor of mortality in infants after cardiopulmonary bypass, 2010,11:234-238), or pediatric patients with combined blood lactate >4 mmol/L, or Cardiopulmonary resuscitation (CPR); (4) CRRT indications: patients with acute kidney injury (AKI) treated with diuretics had urine volume 10%, or hemodynamic instability with severe pulmonary edema (LUS score >15); (5) The age of the patient was from January to 14 years old; (6) Sign informed consent.

Exclusion criteria

Exclusion criteria: (1) With severe intracranial hemorrhage and cerebral functional failure; (2) Children with stem cell transplantation; (3) Tumor and leukemia combined with severe hypoxic respiratory failure, expected survival time <2 years; (4) Patients who discontinued ECMO treatment due to non-medical factors.

Design outcomes

Primary

MeasureTime frame
Hospital survival rate;

Secondary

MeasureTime frame
ECMO withdrawal success rate;60-Day survival rate;Length of PICU stay;Duration of mechanical ventilator;Organ function index;

Countries

China

Contacts

Public ContactYucai Zhang

Shanghai Children's Hospital

zhangyc@shchildren.com.cn+86 18917128301

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026